Apoptosis signal‐regulating kinase‐1 inhibitor as a potent therapeutic drug for the treatment of gastric cancer

Aside from the human epidermal growth factor receptor‐2 (HER2)‐targeting agent trastuzumab, molecular targeting therapy for gastric cancer (GC) has not been established. We previously reported that apoptosis signal‐regulating kinase‐1 (ASK1) was upregulated in human GC and that overexpression of ASK...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Sci
Autori principali: Hayakawa, Yoku, Hirata, Yoshihiro, Sakitani, Kosuke, Nakagawa, Hayato, Nakata, Wachiko, Kinoshita, Hiroto, Takahashi, Ryota, Takeda, Kohsuke, Ichijo, Hidenori, Maeda, Shin, Koike, Kazuhiko
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2012
Soggetti:
Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659227/
https://ncbi.nlm.nih.gov/pubmed/23110662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12024
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi